MAP3K7: A Protein That Regulates Cellular Signaling Pathways (G6885)

Target Name: MAP3K7

NCBI ID: G6885

MAP3K7

MAP3K7: A Protein That Regulates Cellular Signaling Pathways

MAP3K7, also known as Mitogen-activated protein kinase kinase 7 (ISOform B), is a protein that plays a crucial role in cellular signaling pathways. It is a member of the MAPK7 kinase family, which is known for their ability to regulate various cellular processes, including cell growth, differentiation, and survival.

MAP3K7 is a 21-kDa protein that is expressed in various tissues, including muscle, heart, brain, and organs. It is involved in several cellular signaling pathways, including the regulation of cell proliferation, differentiation, and survival. It is also involved in the regulation of cellular signaling pathways that are related to inflammation and stress responses.

One of the well-known functions of MAP3K7 is its role in the regulation of cell proliferation. MAP3K7 has been shown to play a negative role in the regulation of cell proliferation by inhibiting the activities of cell cycle-related proteins. It has been shown that inhibition of MAP3K7 activity can lead to increased cell proliferation and the formation of cancerous tumors.

Another function of MAP3K7 is its role in the regulation of cell differentiation. MAP3K7 has been shown to play a positive role in the regulation of cell differentiation by promoting the activities of genes involved in cell differentiation. It has been shown that inhibition of MAP3K7 activity can lead to a decrease in cell differentiation and a decrease in the formation of functional tissues.

MAP3K7 is also involved in the regulation of cellular signaling pathways that are related to inflammation and stress responses. It has been shown to play a positive role in the regulation of inflammation and stress responses by promoting the activities of genes involved in inflammation and stress responses. It has been shown that inhibition of MAP3K7 activity can lead to a decrease in inflammation and stress responses.

In addition to its role in cellular signaling pathways, MAP3K7 is also involved in the regulation of protein homeostasis. It has been shown to play a positive role in the regulation of protein homeostasis by promoting the activities of genes involved in protein synthesis and degradation. It has been shown that inhibition of MAP3K7 activity can lead to an increase in the misfolding of proteins and an increase in the formation of protein aggregates.

Despite its positive role in several cellular signaling pathways, MAP3K7 has also been shown to play a negative role in several diseases. For example, it has been shown to play a negative role in the development of cancer by promoting the growth and survival of cancer cells. It has also been shown to play a negative role in the regulation of cellular signaling pathways that are involved in inflammation and stress responses, leading to an increase in inflammation and stress responses.

In conclusion, MAP3K7 is a protein that plays a crucial role in cellular signaling pathways. It is involved in the regulation of cell proliferation, differentiation, and survival, as well as the regulation of protein homeostasis and cellular signaling pathways that are related to inflammation and stress responses. Despite its positive role in several cellular signaling pathways, MAP3K7 has also been shown to play a negative role in the development of cancer and the regulation of cellular signaling pathways that are involved in inflammation and stress responses. Therefore, MAP3K7 may be a potential drug target or biomarker for various diseases.

Protein Name: Mitogen-activated Protein Kinase Kinase Kinase 7

Functions: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Mediates signal transduction of TRAF6, various cytokines including interleukin-1 (IL-1), transforming growth factor-beta (TGFB), TGFB-related factors like BMP2 and BMP4, toll-like receptors (TLR), tumor necrosis factor receptor CD40 and B-cell receptor (BCR). Ceramides are also able to activate MAP3K7/TAK1. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K1/MEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks in turn activate p38 MAPKs, c-jun N-terminal kinases (JNKs) and I-kappa-B kinase complex (IKK). Both p38 MAPK and JNK pathways control the transcription factors activator protein-1 (AP-1), while nuclear factor-kappa B is activated by IKK. MAP3K7 activates also IKBKB and MAPK8/JNK1 in response to TRAF6 signaling and mediates BMP2-induced apoptosis. In osmotic stress signaling, plays a major role in the activation of MAPK8/JNK1, but not that of NF-kappa-B. Promotes TRIM5 capsid-specific restriction activity. Phosphorylates RIPK1 at 'Ser-321' which positively regulates RIPK1 interaction with RIPK3 to promote necroptosis but negatively regulates RIPK1 kinase activity and its interaction with FADD to mediate apoptosis (By similarity)

The "MAP3K7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MAP3K7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets